Role of dynorphin in hypoxic pulmonary hypertension

被引:6
作者
Li, Juan [1 ]
Liang, Xiaojie [1 ]
Zhou, Yaguang [1 ]
Zhang, Shumiao [1 ]
Yang, Fan [1 ]
Guo, Haitao [1 ]
Fan, Rong [1 ]
Feng, Na [1 ]
Jia, Min [1 ]
Wang, Yueming [1 ]
Liu, Mingchao [2 ]
Pei, Jianming [1 ]
机构
[1] Fourth Mil Med Univ, Natl Key Discipline Cell Biol, Dept Physiol, Xian 710032, Shaanxi Provinc, Peoples R China
[2] Fourth Mil Med Univ, Sch Publ Hlth, Dept Occupat & Environm Hlth, Xian 710032, Shaanxi Provinc, Peoples R China
基金
中国国家自然科学基金;
关键词
Dynorphin A; Opioid receptor; Pulmonary artery hypertension; Hypoxia; OPIOID RECEPTOR; U50,488H; RATS; ARTERY; EXPRESSION; HEART;
D O I
10.1016/j.ejphar.2016.08.019
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Previously study showed kappa-opioid receptor stimulation with exogenous kappa-opioid receptor agonist elicited a protective effect against hypoxic pulmonary hypertension (HPH). However, the effect of endogenous kappa-opioid receptor agonist dynorphin A on HPH remains unclear. This study was to determine the role of dynorphin in HPH. Hypoxia for 2 weeks induced HPH. Compared with the HPH group, the HPH + nor-BNI (a selective kappa-opioid receptor antagonist) group showed a significant increase in mean pulmonary arterial pressure (mPAP). Exogenous treatment with dynorphin A 1-13 significantly decreased mPAP in HPH rat. In addition, we evaluated the effect of exogenous kappa-opioid receptor agonist U50,488H on mPAP. The anti-HPH effect of dynorphin A was less than that of U50,488H. Meanwhile, level of dynorphin A in serum and lung was increased during hypoxia for 2 weeks, while it decreased after hypoxia for 4 weeks. In addition, both the level of ET-1 and Angll were increased during hypoxia. Dynorphin A 1-13 and U50,488H time-dependently relaxed pulmonary artery from both normal and HPH rats. The relaxation of dynorphin A was less than that of U50,488H. Dynorphin A 1-13 inhibited the proliferation of pulmonary artery smooth muscle cells (PASMCs) during hypoxia, which was blocked by nor-BNI. kappa-opioid receptor expression increased in PASMCs in both normoxia exposed to dynorphin A 1-13 and during hypoxia. Hypoxia-induced increase was enhanced by dynorphin A 1-13 and abolished by nor-BNI. In conclusion, endogenous dynorphin A released in the early stage of hypoxia plays a protective effect against HPH via stimulation of kappa-opioid receptor. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:78 / 84
页数:7
相关论文
共 34 条
[1]   Role of opioids in hypoxic pial artery dilation is stimulus duration dependent [J].
Armstead, WM .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1998, 275 (03) :H861-H867
[2]   Pathogenic mechanisms of pulmonary arterial hypertension [J].
Chan, Stephen Y. ;
Loscalzo, Joseph .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2008, 44 (01) :14-30
[3]   Role of Epidermal Growth Factor Inhibition in Experimental Pulmonary Hypertension [J].
Dahal, Bhola Kumar ;
Cornitescu, Teodora ;
Tretyn, Aleksandra ;
Pullamsetti, Soni Savai ;
Kosanovic, Djuro ;
Dumitrascu, Rio ;
Ghofrani, Hossein Ardeschir ;
Weissmann, Norbert ;
Voswinckel, Robert ;
Banat, Gamal-Andre ;
Seeger, Werner ;
Grimminger, Friedrich ;
Schermuly, Ralph Theo .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181 (02) :158-167
[4]   Pulmonary hypertension [J].
Gaine, S .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (24) :3160-3168
[5]   Endogenous κ-Opioid Peptide Mediates the Cardioprotection Induced by Ischemic Postconditioning [J].
Guo, Hai-Tao ;
Zhang, Rong-Huai ;
Zhang, Yan ;
Zhang, Li-Jun ;
Li, Juan ;
Shi, Quang-Xing ;
Wang, Yue-Min ;
Fan, Rong ;
Bi, Hui ;
Yin, Wen ;
Pei, Jian-Ming .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2011, 58 (02) :207-215
[6]   SMALL PULMONARY ARTERIAL VESSELS OF AYMARA INDIANS FROM THE BOLIVIAN ANDES [J].
HEATH, D ;
WILLIAMS, D ;
RIOSDALENZ, J ;
CALDERON, M ;
GOSNEY, J .
HISTOPATHOLOGY, 1990, 16 (06) :565-571
[7]   Endothelial cell dysfunction and cross talk between endothelium and smooth muscle cells in pulmonary arterial hypertension [J].
Humbert, Marc ;
Montani, David ;
Perros, Frederic ;
Dorfmueller, Peter ;
Adnot, Serge ;
Eddahibi, Saadia .
VASCULAR PHARMACOLOGY, 2008, 49 (4-6) :113-118
[8]   Pulmonary vascular remodeling: a target for therapeutic intervention in pulmonary hypertension [J].
Jeffery, TK ;
Wanstall, JC .
PHARMACOLOGY & THERAPEUTICS, 2001, 92 (01) :1-20
[9]   INCREASED SENSITIVITY TO INSULIN-RELEASING AND GLUCOREGULATORY EFFECTS OF DYNORPHIN-A1-13 AND U-50488H IN OB/OB VERSUS LEAN MICE [J].
KHAWAJA, XZ ;
GREEN, IC ;
THORPE, JR ;
BAILEY, CJ .
DIABETES, 1990, 39 (10) :1289-1297
[10]   Vasculoprotective effect of U50,488H in rats exposed to chronic hypoxia: role of Akt-stimulated NO production [J].
Li, Juan ;
Shi, Quan-Xing ;
Fan, Rong ;
Zhang, Li-Jun ;
Zhang, Shu-Miao ;
Guo, Hai-Tao ;
Wang, Yue-Min ;
Kaye, Aaron Joshua ;
Kaye, Alan David ;
Bueno, Franklin Rivera ;
Xu, Xue-Zeng ;
Yu, Shi-Qiang ;
Yi, Ding-Hua ;
Pei, Jian-Ming .
JOURNAL OF APPLIED PHYSIOLOGY, 2013, 114 (02) :238-244